Oncology & Cancer

Metformin linked to lower risk of head, neck cancer

(HealthDay)—Metformin is associated with a lower risk of developing head and neck cancer in patients with diabetes, according to a study published in the September issue of Head & Neck.

Oncology & Cancer

Large study uncovers molecular alterations in head and neck cancers

Investigators with The Cancer Genome Atlas (TCGA) Research Network have discovered genomic differences - with potentially important clinical implications - in head and neck cancers caused by infection with the human papillomavirus ...

Oncology & Cancer

Lawson researchers take control of cancer

According to the Canadian Cancer Society, one in four Canadians will die of cancer. This year alone, the disease will kill an estimated 75,000 people. With incidence rates on the rise, more cancer patients are facing grave ...

page 5 from 12